Barely Significant
← all excerpts

A novel biomarker of MMP-cleaved prolargin is elevated in patients with psoriatic arthritis.

Sci Rep · 2020 · PMC7419545 · PMID 32782251

Europe PMCDOI
1
hedged sentence
0.0490
closest p · 1.0× alpha
0.0490
boldest claim

The sentences

borderline significantp = 0.049actually significant
After 24 weeks, the level of prolargin showed a borderline significant decrease in the placebo group (p = 0.049), but no difference was observed in the n-3 polyunsaturated fatty acid (PUFA) treated group (Fig. 4 ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.